It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Suspected central nervous system (CNS) infections may pose a diagnostic challenge, and often concern severely ill patients. We aim to identify predictors of unfavourable outcome to prioritize diagnostics and treatment improvements. Unfavourable outcome was assessed on the Glasgow Outcome Scale at hospital discharge, defined by a score of 1 to 4. Of the 1152 episodes with suspected CNS infection, from two Dutch prospective cohorts, the median age was 54 (IQR 37–67), and 563 episodes (49%) occurred in women. The final diagnoses were categorized as CNS infection (N = 358 episodes, 31%), CNS inflammatory disease (N = 113, 10%), non-infectious non-inflammatory neurological disorder (N = 388, 34%), non-neurological infection (N = 252, 22%), and other systemic disorder (N = 41, 4%). Unfavourable outcome occurred in 412 of 1152 (36%), and 99 died (9%). Predictors for unfavourable outcomes included advanced age, absence of headache, tachycardia, altered mental state, focal cerebral deficits, cranial nerve palsies, low thrombocytes, high CSF protein, and the final diagnosis of CNS inflammatory disease (odds ratio 4.5 [95% confidence interval 1.5–12.6]). Episodes suspected of having a CNS infection face high risk of experiencing unfavourable outcome, stressing the urgent need for rapid and accurate diagnostics. Amongst the suspected CNS infection group, those diagnosed with CNS inflammatory disease have the highest risk.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Amsterdam, Amsterdam UMC, Department of Neurology, Amsterdam Neuroscience, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262)
2 Erasmus MC, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:0000 0004 0459 992X)
3 Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands (GRID:grid.440209.b) (ISNI:0000 0004 0501 8269)
4 Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands (GRID:grid.491364.d)
5 Spaarne Gasthuis, Haarlem, The Netherlands (GRID:grid.465804.b) (ISNI:0000 0004 0407 5923)
6 Haaglanden MC, Den Haag, The Netherlands (GRID:grid.465804.b)
7 Flevoziekenhuis, Almere, The Netherlands (GRID:grid.440159.d) (ISNI:0000 0004 0497 5219)
8 Amsterdam UMC, Amsterdam, The Netherlands (GRID:grid.509540.d) (ISNI:0000 0004 6880 3010)
9 Haga Ziekenhuis, Den Haag, The Netherlands (GRID:grid.413591.b) (ISNI:0000 0004 0568 6689)
10 Haaglanden MC, Den Haag, The Netherlands (GRID:grid.413591.b)
11 Alrijne Ziekenhuis, Leiden, The Netherlands (GRID:grid.476994.1)
12 Albert Schweitzer ziekenhuis, Dordrecht, The Netherlands (GRID:grid.413972.a) (ISNI:0000 0004 0396 792X)